ConductScience.org, home

Paper102245

Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.

Wise R and 2 others. Antimicrob Agents Chemother, 1978. Cited by 37 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs. Papers, record 102245. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/102245

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
2.21
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wise RR
2Andrews JMJ M
3Bedford KAK A

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
CefoxitinMajor topic
CephalosporinsMajor topic
PenicillinsMajor topic
Azlocillin
Bacteroides fragilis
Enterobacteriaceae
Haemophilus influenzae
Imidazolidines
Neisseria gonorrhoeae
Pseudomonas aeruginosa
Staphylococcus aureus
Streptococcus

Source PubMed

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,041,216BL-P1654: a bacteriostatic penicillin?Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1041216PubMed
218,083Azlocillin: in vitro studies of a new semisynthetic penicillin.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/18083PubMed
34,208,895Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4208895PubMed
44,210,893Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic.Chemotherapy1974https://conductscience.org/library/papers/4210893PubMed
5810,304Clinical evaluation of carbenicillin in the treatment of infection due to anaerobic bacteria.Curr Ther Res Clin Exp1975https://conductscience.org/library/papers/810304PubMed
6836,016Mezlocillin: in vitro studies of a new broad-spectrum penicillin.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/836016PubMed
7921,239In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/921239PubMed
896,726Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/96726PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
7,152,690Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.Infection1982https://conductscience.org/library/papers/7152690PubMed
7,007,327Effects of furazlocillin, a beta-lactam antibiotic which binds selectively to penicillin-binding protein 3, on Escherichia coli mutants deficient in other penicillin-binding proteins.J Bacteriol1981https://conductscience.org/library/papers/7007327PubMed
6,875,810The pharmacokinetics of furazlocillin in healthy humans.J Pharmacokinet Biopharm1983https://conductscience.org/library/papers/6875810PubMed
6,450,748Evidence for involvement of penicillin-binding protein 3 in murein synthesis during septation but not during cell elongation.J Bacteriol1981https://conductscience.org/library/papers/6450748PubMed
6,449,903Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6449903PubMed
6,448,577Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6448577PubMed
6,448,229Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.Infection1980https://conductscience.org/library/papers/6448229PubMed
6,448,020Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6448020PubMed
6,391,888Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs1984https://conductscience.org/library/papers/6391888PubMed
6,344,786Selection and characterization of beta-lactam-resistant Escherichia coli K-12 mutants.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6344786PubMed
6,321,446Use of ureidopenicillins for selection of plasmid vector transformants in Pseudomonas aeruginosa and Pseudomonas putida.J Bacteriol1984https://conductscience.org/library/papers/6321446PubMed
3,983,886Adverse reactions to piperacillin in adults with cystic fibrosis.Thorax1985https://conductscience.org/library/papers/3983886PubMed
3,729,353Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3729353PubMed
525,984Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/525984PubMed
485,123Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/485123PubMed
475,364In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/475364PubMed
228,593Activity of semisynthetic penicillins and synergism with mecillinam against Bacteroides species.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/228593PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/102245

GET https://conductscience.org/api/papers/v1/102245/authors